Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Ottawa
$105,000.00
Dissecting Signaling Pathways Regulating Internal Ribosome Entry Site-mediated Translation
EF 2008-09
Résumé
Programmed cell death, or apoptosis, is crucial in protecting against human disease, particularly in cells that have incurred DNA damage or have pathogenic properties. XIAP and Bcl-xL are members of the two classes of proteins that control apoptosis. The regulation of these proteins is particularly important in cancer, where the resistance to apoptosis is implicated in disease progression and resistance to chemotherapy, a major problem encountered in the treatment of most cancers, including small cell lung cancer (SCLC). Fibroblast growth factor 2 (FGF-2), and the subsequent activation of ribosomal protein S6 kinase 2 (S6K2), were shown to protect SCLC cells from chemotherapeutic drug-induced cell death because it upregulates XIAP and Bcl-xL protein levels in the cell. However, the mechanism through which XIAP and Bcl-xL are upregulated is not known. Expression of XIAP and Bcl-xL is controlled by a specific regulatory sequence (internal ribosome entry site (IRES)) in their transcripts that allows for both proteins to be generated during times of cellular stress when global protein translation is limited. Therefore, the primary focus of my research will be examining the signaling pathways that affect IRES translation of XIAP and Bcl-xL, particularly through S6K2, which targets many proteins involved in various aspects of translational regulation.
I propose to identify the downstream target of S6K2 in the IRES-mediated upregulation of XIAP and Bcl-xL. I envision that this work will underscore the importance of understanding signaling cascades that regulate IRES-mediated translation under both normal and pathological cellular conditions, but may also potentially identify new targets that play a role in overall resistance to chemotherapy encountered in the treatment of SCLC, as well as other cancers.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
184668
Name
Jordan Lindsay E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Dissecting Signaling Pathways Regulating Internal Ribosome Entry Site-mediated Translation
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Apoptosis; Bcl-Xl; Cancer; Ires; Pdcd4; Rna Binding Proteins; S6 Kinase 2; Translation; Translational Control; Xiap
Abstract
Programmed cell death, or apoptosis, is crucial in protecting against human disease, particularly in cells that have incurred DNA damage or have pathogenic properties. XIAP and Bcl-xL are members of the two classes of proteins that control apoptosis. The regulation of these proteins is particularly important in cancer, where the resistance to apoptosis is implicated in disease progression and resistance to chemotherapy, a major problem encountered in the treatment of most cancers, including small cell lung cancer (SCLC). Fibroblast growth factor 2 (FGF-2), and the subsequent activation of ribosomal protein S6 kinase 2 (S6K2), were shown to protect SCLC cells from chemotherapeutic drug-induced cell death because it upregulates XIAP and Bcl-xL protein levels in the cell. However, the mechanism through which XIAP and Bcl-xL are upregulated is not known. Expression of XIAP and Bcl-xL is controlled by a specific regulatory sequence (internal ribosome entry site (IRES)) in their transcripts that allows for both proteins to be generated during times of cellular stress when global protein translation is limited. Therefore, the primary focus of my research will be examining the signaling pathways that affect IRES translation of XIAP and Bcl-xL, particularly through S6K2, which targets many proteins involved in various aspects of translational regulation.
I propose to identify the downstream target of S6K2 in the IRES-mediated upregulation of XIAP and Bcl-xL. I envision that this work will underscore the importance of understanding signaling cascades that regulate IRES-mediated translation under both normal and pathological cellular conditions, but may also potentially identify new targets that play a role in overall resistance to chemotherapy encountered in the treatment of SCLC, as well as other cancers.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Jordan, Lindsay E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~